Juan Caeiro is an Infectious Disease physician. OpenAlex indexes 77 publications with 1,482 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6624 Fannin St
Suite 1450
Houston, TX 770302312
Telephone
713-383-6882Registry record last updated 3 Aug 2010.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year202526 payments
- ViiV Healthcare CompanyProgram year20254 payments
- EMD Serono, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
42.1%Statin18.6%Atorvastatin Calcium63%Rosuvastatin Calcium18%Pravastatin Sodium17%Simvastatin3%Part D<11 patientsACE inhibitor8.5%Lisinopril70%Benazepril Hcl22%Lisinopril-Hydrochlorothiazide8%Part D<11 patients+ 7 more classes in this area
Anti-infectives
22.9%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor8.1%Descovy68%Triumeq25%Abacavir7%Part D<11 patientsProtease Inhibitor5.5%Ritonavir26%Darunavir21%Symtuza17%Prezista13%Evotaz12%Norvir11%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
15%Biguanide (metformin)3.2%Metformin Hcl100%Part D<11 patientsProton pump inhibitor3.1%Omeprazole68%Pantoprazole Sodium32%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics
Travel Medicine and Infectious Disease
2023 - Antifungal stewardship: the Latin American experience
Antimicrobial Stewardship & Healthcare Epidemiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”